MARY1
Product Specifications
Target
5-HT Receptor, Akt, Ras, ERK, MEK, PI3K
Related Pathways
Metabolism, PI3K/Akt/mTOR signaling, GPCR/G Protein, MAPK, Neuroscience, Cytoskeletal Signaling
Bioactivity
MARY1 is a selective 5-HT2BR antagonist with an IC50 of 380 nM and a Ki of 764 nM [human 5-HT2BR]. It promotes mitochondrial biogenesis (MB) in the kidneys and enhances mitochondrial function by increasing mitochondrial respiration capacity, protein levels, and number in renal proximal tubular cells (RPTC) . MARY1 induces MB in RPTCs through the 5-HT2BR and dual PI3K/AKT and RAS/MEK/ERK signaling pathways. It is useful for studying kidney diseases related to metabolic and mitochondrial dysfunction.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6156390-01 0.1 mL
ADAM12 (Disintegrin and Metalloproteinase Domain-containing Protein 12, ADAM 12, Meltrin-alpha, MLTN, UNQ346/PRO545) (PE)
Sign In for Pricing
View Details 
MBS6156390-02 5x 0.1 mL
ADAM12 (Disintegrin and Metalloproteinase Domain-containing Protein 12, ADAM 12, Meltrin-alpha, MLTN, UNQ346/PRO545) (PE)
Sign In for Pricing
View Details 
MBS9021832-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Saccharopepsin (PEP4)
Sign In for Pricing
View Details